BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30515933)

  • 1. Cullin-3/KCTD10 E3 complex is essential for Rac1 activation through RhoB degradation in human epidermal growth factor receptor 2-positive breast cancer cells.
    Murakami A; Maekawa M; Kawai K; Nakayama J; Araki N; Semba K; Taguchi T; Kamei Y; Takada Y; Higashiyama S
    Cancer Sci; 2019 Feb; 110(2):650-661. PubMed ID: 30515933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP.
    Nishiyama K; Maekawa M; Nakagita T; Nakayama J; Kiyoi T; Chosei M; Murakami A; Kamei Y; Takeda H; Takada Y; Higashiyama S
    Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34187934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCTD10 Biology: An Adaptor for the Ubiquitin E3 Complex Meets Multiple Substrates: Emerging Divergent Roles of the cullin-3/KCTD10 E3 Ubiquitin Ligase Complex in Various Cell Lines.
    Maekawa M; Higashiyama S
    Bioessays; 2020 Aug; 42(8):e1900256. PubMed ID: 32484264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cullin-3-Rbx1-KCTD10 complex controls endothelial barrier function via K63 ubiquitination of RhoB.
    Kovačević I; Sakaue T; Majoleé J; Pronk MC; Maekawa M; Geerts D; Fernandez-Borja M; Higashiyama S; Hordijk PL
    J Cell Biol; 2018 Mar; 217(3):1015-1032. PubMed ID: 29358211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cullin-3/KCTD10 complex is essential for K27-polyubiquitination of EIF3D in human hepatocellular carcinoma HepG2 cells.
    Maekawa M; Hiyoshi H; Nakayama J; Kido K; Sawasaki T; Semba K; Kubota E; Joh T; Higashiyama S
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1116-1122. PubMed ID: 31280863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoB controls endothelial barrier recovery by inhibiting Rac1 trafficking to the cell border.
    Marcos-Ramiro B; García-Weber D; Barroso S; Feito J; Ortega MC; Cernuda-Morollón E; Reglero-Real N; Fernández-Martín L; Durán MC; Alonso MA; Correas I; Cox S; Ridley AJ; Millán J
    J Cell Biol; 2016 May; 213(3):385-402. PubMed ID: 27138256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase.
    Wherlock M; Gampel A; Futter C; Mellor H
    J Cell Sci; 2004 Jul; 117(Pt 15):3221-31. PubMed ID: 15226397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neddylation-cullin 2-RBX1 E3 ligase axis targets tumor suppressor RhoB for degradation in liver cancer.
    Xu J; Li L; Yu G; Ying W; Gao Q; Zhang W; Li X; Ding C; Jiang Y; Wei D; Duan S; Lei Q; Li P; Shi T; Qian X; Qin J; Jia L
    Mol Cell Proteomics; 2015 Mar; 14(3):499-509. PubMed ID: 25540389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUL3-KBTBD6/KBTBD7 ubiquitin ligase cooperates with GABARAP proteins to spatially restrict TIAM1-RAC1 signaling.
    Genau HM; Huber J; Baschieri F; Akutsu M; Dötsch V; Farhan H; Rogov V; Behrends C
    Mol Cell; 2015 Mar; 57(6):995-1010. PubMed ID: 25684205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cullin-3-KCTD10-mediated CEP97 degradation promotes primary cilium formation.
    Nagai T; Mukoyama S; Kagiwada H; Goshima N; Mizuno K
    J Cell Sci; 2018 Dec; 131(24):. PubMed ID: 30404837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallels between single cell migration and barrier formation: The case of RhoB and Rac1 trafficking.
    García-Weber D; Millán J
    Small GTPases; 2018 Jul; 9(4):332-338. PubMed ID: 27598909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells.
    Zhao Y; Wang Z; Jiang Y; Yang C
    Cancer Lett; 2011 Dec; 313(1):54-63. PubMed ID: 21943825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DLC3 suppresses MT1-MMP-dependent matrix degradation by controlling RhoB and actin remodeling at endosomal membranes.
    Noll B; Benz D; Frey Y; Meyer F; Lauinger M; Eisler SA; Schmid S; Hordijk PL; Olayioye MA
    J Cell Sci; 2019 Jun; 132(11):. PubMed ID: 31076513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arf6 regulates RhoB subcellular localization to control cancer cell invasion.
    Zaoui K; Rajadurai CV; Duhamel S; Park M
    J Cell Biol; 2019 Nov; 218(11):3812-3826. PubMed ID: 31591185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoB regulates endosome transport by promoting actin assembly on endosomal membranes through Dia1.
    Fernandez-Borja M; Janssen L; Verwoerd D; Hordijk P; Neefjes J
    J Cell Sci; 2005 Jun; 118(Pt 12):2661-70. PubMed ID: 15944396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoB and the mammalian Diaphanous-related formin mDia2 in endosome trafficking.
    Wallar BJ; Deward AD; Resau JH; Alberts AS
    Exp Cell Res; 2007 Feb; 313(3):560-71. PubMed ID: 17198702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARF6 promotes the formation of Rac1 and WAVE-dependent ventral F-actin rosettes in breast cancer cells in response to epidermal growth factor.
    Marchesin V; Montagnac G; Chavrier P
    PLoS One; 2015; 10(3):e0121747. PubMed ID: 25799492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and cytoprotective activity of the small GTPase RhoB induced by the Escherichia coli cytotoxic necrotizing factor 1.
    Huelsenbeck SC; Roggenkamp D; May M; Huelsenbeck J; Brakebusch C; Rottner K; Ladwein M; Just I; Fritz G; Schmidt G; Genth H
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1767-75. PubMed ID: 23732113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARF1 controls Rac1 signaling to regulate migration of MDA-MB-231 invasive breast cancer cells.
    Lewis-Saravalli S; Campbell S; Claing A
    Cell Signal; 2013 Sep; 25(9):1813-9. PubMed ID: 23707487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.